1. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
   Xianwen Hu et al, 2022, Front. Oncol. CrossRef
2. Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis
   Siji Lv et al, 2022, Analytical Cellular Pathology CrossRef
3. BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
   Sihan Chen et al, 2022, Front. Oncol. CrossRef
4. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
   Qiaonan Guo et al, 2022, Disease Markers CrossRef
5. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer
   Baohong Jiang et al, 2022, Disease Markers CrossRef
6. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
   Kai Wang et al, 2022, Disease Markers CrossRef
7. ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration
   Can Wang et al, 2022, Disease Markers CrossRef
8. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
   Daniele Marrelli et al, 2022, Cancers CrossRef
9. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes
   Ruobing Leng et al, 2022, Front. Oncol. CrossRef
10. Polygenic Risk Score Predicts Modified Risk in BRCA1 Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
    Egija Berga-Švītiņa et al, 2023, Cancers CrossRef
11. MicroRNAs as Potential Biomarkers in Gynecological Cancers
    Joanna Miśkiewicz et al, 2023, Biomedicines CrossRef
12. HIPEC for gynaecological malignancies: A last update (Review)
    Chrysoula Margioula‑Siarkou et al, 2023, Med Int CrossRef
13. Vitamin D and microRNAs: Role in the pathogenesis and prognosis of breast cancer (Review)
    Luca Falzone et al, 2023, Int J Epigen CrossRef
14. BRCA Mutations and Fertility Preservation
    Joana Dias Nunes et al, 2023, IJMS CrossRef
15. BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
    Salma Wahabi Alzahabi et al, 2024, Egypt J Med Hum Genet CrossRef
16. Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors
    Gyongyver Szentmartoni et al, 2024, Biomedicines CrossRef
17. Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots
    Giuseppe Gattuso et al, 2024, Int J Mol Med CrossRef
18. Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer
    Yue Ding et al, 2024, Mol Biotechnol CrossRef
19. Public neoantigens in breast cancer immunotherapy (Review)
    Natthaporn Sueangoen et al, 2024, Int J Mol Med CrossRef
20. Resistance of HER2-expressing breast cancer patients treated with trastuzumab: Underlying mechanisms of resistance and reversals
    Hannah Romano et al, 2024 CrossRef
21. MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review
    Henny Meitri Andrie Putri et al, 2024, Oncol Lett CrossRef
22. Role of ethnic and genetic factors in the development of prostate cancer (Review)
    Timur Saliev et al, 2024, World Acad Sci J CrossRef